SMARTVITAL+
DEAD

Serial Number

90731919

Owner

Lexical AI, Inc

Filing Date

May 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SMARTVITAL+ Trademark

Serial Number: 90731919

SMARTVITAL+ is a trademark filed by Lexical AI, Inc on May 24, 2021. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Lexical AI, Inc (3 trademarks)

Deerfield Beach, FL 33064

Entity Type: 03

Trademark Details

Filing Date

May 24, 2021

Registration Date

Not Registered

Published for Opposition

October 15, 2024

Goods & Services

Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, body weight and cardiac output; Medical apparatus and instruments for monitoring vital signs that result in emergent health events and alerts while the patient is sleeping, namely, vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, cardiac output for nightly patient monitoring; Medical apparatus and instruments for monitoring vital signs to detect sleep apnea while the patient is sleeping, namely, vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, excessive movement, restlessness, respiratory rate and cardiac output; Medical apparatus and instruments for monitoring patients vital signs aging at home, patients' vital signs who need home assistance, patients' vital signs recovering from postoperative surgery, patients' vital signs undergoing preoperative approval for surgery, patients' vital signs in a contaminated environment, patients' vital signs who are quarantined, patients' vital signs with acute undefined illness; Medical apparatus and instruments for monitoring vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, body weight and cardiac output for a patient who is attending a virtual telemedicine visit; Medical apparatus and instruments for monitoring health, namely, vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, body weight and cardiac output; Medical apparatus and instruments for treating cardiovascular disease; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of a central processing unit, computer memory, local area network hardware, wireless speakers, wireless routers, data storage, data transfer, remote monitoring, machined learning models, deep learning neural networks and led screens for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for treating sleep disorders; Medical devices for use in treating or diagnosing coronavirus, flu, colds, cardiac arrhythmias, atrial fibrillation, ventricular fibrillation, p waves, hypertension, sepsis, fever, sleep apnea, sleeping disorders, pneumonia and respiratory illnesses; Medical devices, namely, pulse oximeters

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 30, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 30, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2024 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 18, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 1, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 1, 2023 GNSL
SUSPENSION LETTER WRITTEN
Apr 1, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 4, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 4, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 4, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 4, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2023 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2023 TEME
ASSIGNED TO LIE
Jan 18, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 17, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 17, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 17, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 17, 2022 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 14, 2022 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 14, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 13, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 13, 2022 GNSL
SUSPENSION LETTER WRITTEN
Apr 13, 2022 CNSL
EXAMINER'S AMENDMENT ENTERED
Apr 13, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 13, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 13, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 13, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 6, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2021 NWOS
NEW APPLICATION ENTERED
May 27, 2021 NWAP